BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 24131374)

  • 1. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis.
    Lemos EV; de la Hoz FP; Einarson TR; McGhan WF; Quevedo E; Castañeda C; Kawai K
    Clin Microbiol Infect; 2014 May; 20(5):416-23. PubMed ID: 24131374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.
    Zheng YL; Wan YF; Zhou LY; Ye ML; Liu S; Xu CQ; He YQ; Chen JH
    Am J Infect Control; 2013 Jul; 41(7):e59-63. PubMed ID: 23523521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
    Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
    Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia in the neonate: A case-case-control study.
    Thatrimontrichai A; Techato C; Dissaneevate S; Janjindamai W; Maneenil G; Kritsaneepaiboon S; Tanaanantarak P
    J Infect Chemother; 2016 Jul; 22(7):444-9. PubMed ID: 27229539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in
    Liu Y; Wang Q; Zhao C; Chen H; Li H; Wang H; Cares Network OBOT
    J Med Microbiol; 2020 Jul; 69(7):949-959. PubMed ID: 32584215
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical characteristics and outcomes of community and hospital-acquired Acinetobacter baumannii bacteremia.
    Chusri S; Chongsuvivatwong V; Silpapojakul K; Singkhamanan K; Hortiwakul T; Charernmak B; Doi Y
    J Microbiol Immunol Infect; 2019 Oct; 52(5):796-806. PubMed ID: 31031096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis.
    Du X; Xu X; Yao J; Deng K; Chen S; Shen Z; Yang L; Feng G
    Am J Infect Control; 2019 Sep; 47(9):1140-1145. PubMed ID: 31003750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Epidemiological Significance of Carbapenem Resistance in Acinetobacter baumannii Infections.
    Tal-Jasper R; Katz DE; Amrami N; Ravid D; Avivi D; Zaidenstein R; Lazarovitch T; Dadon M; Kaye KS; Marchaim D
    Antimicrob Agents Chemother; 2016 May; 60(5):3127-31. PubMed ID: 26883694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk factors and resistance patterns of invasive
    Ge YL; Shan QW; Qiu Y; Zhou SP; Cheng YB; Wang F; Yang JW; Wan CM; Zhu Y; Xu Y; Chen MX; Lin DJ; Zhu CH; Zeng M
    Zhonghua Er Ke Za Zhi; 2022 Aug; 60(8):762-768. PubMed ID: 35922185
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis.
    Lyu C; Zhang Y; Liu X; Wu J; Zhang J
    BMC Infect Dis; 2020 Apr; 20(1):296. PubMed ID: 32316926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality attributable to carbapenem-resistant nosocomial Acinetobacter baumannii infections in a Turkish university hospital.
    Aydemir H; Celebi G; Piskin N; Oztoprak N; Keskin AS; Aktas E; Sumbuloglu V; Akduman D
    Jpn J Infect Dis; 2012; 65(1):66-71. PubMed ID: 22274161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
    Huang ST; Chiang MC; Kuo SC; Lee YT; Chiang TH; Yang SP; Ti-Yin ; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2012 Oct; 45(5):356-62. PubMed ID: 22575430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case-control study.
    Henig O; Weber G; Hoshen MB; Paul M; German L; Neuberger A; Gluzman I; Berlin A; Shapira C; Balicer RD
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2063-8. PubMed ID: 26205665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Status of carbapenem-resistant Acinetobacter baumannii harboring carbapenemase: First systematic review and meta-analysis from Iran.
    Beigverdi R; Sattari-Maraji A; Emaneini M; Jabalameli F
    Infect Genet Evol; 2019 Sep; 73():433-443. PubMed ID: 31176030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections.
    Esterly JS; Griffith M; Qi C; Malczynski M; Postelnick MJ; Scheetz MH
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4844-9. PubMed ID: 21825287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study.
    Chusri S; Silpapojakul K; McNeil E; Singkhamanan K; Chongsuvivatwong V
    J Infect Chemother; 2015 Feb; 21(2):90-5. PubMed ID: 25454216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC
    Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparison of genotyping, antibiogram, and antimicrobial resistance genes between carbapenem-susceptible and -resistant Acinetobacter baumannii.
    Chen CM; Ke SC; Li CR; Chang CC
    Comp Immunol Microbiol Infect Dis; 2014 Dec; 37(5-6):339-46. PubMed ID: 25456639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and impact of imipenem resistance in Acinetobacter baumannii.
    Lautenbach E; Synnestvedt M; Weiner MG; Bilker WB; Vo L; Schein J; Kim M
    Infect Control Hosp Epidemiol; 2009 Dec; 30(12):1186-92. PubMed ID: 19860563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of clinical characteristics and antimicrobial resistance of carbapenem-resistant Acinetobacter baumannii infections in children].
    Zhang TQ; Dong L; Wang ZY; Li HY
    Zhonghua Er Ke Za Zhi; 2011 Jul; 49(7):545-9. PubMed ID: 22088187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.